KRAS and acute lymphoblastic leukemia: Meanwhile, NRAS (17%), FLT3 (14%), KRAS (9%), SETD2 (7%), PAX5 (6%), and CREBBP (6%) were the most common sequence variants in B-ALL (Supplement Fig. S5).